Reiko Irie

Title: Reiko Irie: Innovator in Antibody Research

Introduction

Reiko Irie is a prominent inventor based in Pacific Palisades, California. She has made significant contributions to the field of antibody research, particularly in the development of anti-ganglioside antibodies. With a total of two patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Reiko Irie's latest patents include innovative methods for producing IgM antibodies. One patent details how IgM can be obtained in the form of a pentamer by placing the genes encoding the H, L, and J chains on the same vector to transform appropriate host cells. The gene encoding the J chain may be introduced by co-transfection. When no J chain is expressed, the IgM is produced as a hexamer. The transformants obtained according to this invention achieve a high yield of IgM. Additionally, her patents provide methods that enable the separation and quantification of polymeric IgM.

Career Highlights

Reiko Irie is associated with Chugai Seiyaku Kabushiki Kaisha, a company known for its focus on pharmaceutical innovations. Her work at this organization has allowed her to explore and develop groundbreaking techniques in antibody production.

Collaborations

Some of her notable coworkers include Hiroyuki Tsunoda and Tomoyuki Igawa. Their collaboration has likely contributed to the advancements in the research and development of antibody technologies.

Conclusion

Reiko Irie is a trailblazer in the field of antibody research, with her innovative patents paving the way for future advancements. Her contributions to the scientific community are invaluable and continue to inspire further research in this critical area.